tiprankstipranks
Trending News
More News >
Bicycle Therapeutics (BCYC)
:BCYC
US Market
Advertisement

Bicycle Therapeutics (BCYC) Technical Analysis

Compare
402 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Bicycle Therapeutics’s (BCYC) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Bicycle Therapeutics is a Sell.
Bicycle Therapeutics’s (BCYC) 20-Day exponential moving average is 6.95, while Bicycle Therapeutics’s (BCYC) share price is $6.87, making it a Buy.
Bicycle Therapeutics’s (BCYC) 50-Day exponential moving average is 7.22, while Bicycle Therapeutics’s (BCYC) share price is $6.87, making it a Sell.

Bicycle Therapeutics (BCYC) Pivot Points

Dec 04, 2025, 10:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.52
6.68
6.77
6.93
7.03
7.19
7.28
Fibonacci
6.68
6.77
6.83
6.93
7.03
7.09
7.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bicycle Therapeutics (BCYC) Moving Averages

Dec 04, 2025, 10:23 AM
Period
Simple
Exponential
MA5
7.17Sell
7.04Buy
MA10
6.82Buy
6.94Buy
MA20
6.66Buy
6.95Buy
MA50
7.50Sell
7.22Sell
MA100
7.51Sell
7.63Sell
MA200
8.04Sell
8.85Sell
Bicycle Therapeutics’s (BCYC) 10-Day exponential moving average is 6.94, while Bicycle Therapeutics’s (BCYC) share price is $6.87, making it a Buy.
Bicycle Therapeutics’s (BCYC) 100-Day exponential moving average is 7.63, while Bicycle Therapeutics’s (BCYC) share price is $6.87, making it a Sell.
Bicycle Therapeutics’s (BCYC) stock price is $6.87 and Bicycle Therapeutics’s (BCYC) 50-day simple moving average is 7.50, creating a Sell signal.
Bicycle Therapeutics’s (BCYC) stock price is $6.87 and Bicycle Therapeutics’s (BCYC) 100-day simple moving average is 7.51, creating a Sell signal.
Bicycle Therapeutics’s (BCYC) stock price is $6.87 and Bicycle Therapeutics’s (BCYC) 200-day simple moving average is 8.04, creating a Sell signal.

Bicycle Therapeutics (BCYC) Technical Indicators

Dec 04, 2025, 10:23 AM
Name
Value
Implied Action
RSI (14)
51.77
Neutral
STOCH (9,6)
54.81
Neutral
STOCHRSI (14)
54.81
Neutral
MACD (12,26)
-0.10
Sell
ADX (14)
18.40
Buy
Williams %R
-38.33
Buy
CCI (14)
88.75
Neutral
ATR (14)
0.47
-
Ultimate Oscillator
53.84
Neutral
ROC
8.84
Buy
Bicycle Therapeutics’s (BCYC) Relative Strength Index (RSI) is 51.77, creating a Neutral signal.
Bicycle Therapeutics’s (BCYC) Trend Strength Indicator (ADX) is 18.40, creating a Buy signal.
Bicycle Therapeutics’s (BCYC) Commodity Channel Index (CCI) is 88.75, creating a Neutral signal.
Bicycle Therapeutics’s (BCYC) Price Rate of Change (ROC) is 8.84, creating a Buy signal.

FAQ

Is BCYC a Buy, Hold, or Sell?
Based on BCYC’s technical indicators, BCYC is a Hold.
    What is BCYC’s RSI (14)?
    BCYC’s RSI (14) is 51.77, which suggests BCYC is a Neutral.
      What is BCYC’s MACD?
      BCYC’s MACD is -0.10, which suggests BCYC is a Sell.
        What is BCYC’s 5-day moving average?
        BCYC’s 5-day moving average is 7.17, which suggests BCYC is a Sell.
          What is BCYC’s 20-day moving average?
          BCYC 20-day moving average is 6.66, which suggests BCYC is a Buy.
            What is BCYC’s 50-day moving average?
            BCYC’s 50-day moving average is 7.50, which suggests BCYC is a Sell.
              What is BCYC’s 200-day moving average?
              BCYC’s 200-day moving average is 8.04, which suggests BCYC is a Sell.
                What is BCYC’s Williams % R (14)?
                BCYC’s Williams % R (14) is -38.33, which suggests BCYC is a Buy.
                  What is BCYC’s CCI (14)?
                  BCYC’s CCI (14) is 88.75, which suggests BCYC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis